Home/Filings/4/0000899243-22-004214
4//SEC Filing

Arnold Lee D 4

Accession 0000899243-22-004214

CIK 0001822711other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 7:04 PM ET

Size

5.8 KB

Accession

0000899243-22-004214

Insider Transaction Report

Form 4
Period: 2022-02-01
Arnold Lee D
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-01+100,000100,000 total
    Exercise: $11.32Exp: 2032-01-31Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]This option shall vest in substantially equal monthly installments over four years from February 1, 2022, subject to a continued service relationship. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2021 Stock Option and Incentive Plan with the U.S. Securities and Exchange Commission.

Issuer

PARDES BIOSCIENCES, INC.

CIK 0001822711

Entity typeother

Related Parties

1
  • filerCIK 0001613258

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 7:04 PM ET
Size
5.8 KB